Opus KSD, Inc. — SEC Form D Filing

Opus KSD, Inc. filed an SEC Form D on October 1, 2026, reporting $681K raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
October 1, 2026
Amount reported
$681K
Round stage
Seed
Industry
Medical Devices
Website
https://www.subq-it.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Current methods for closing surgical incisions, such as sutures and metal staples, are time-consuming for medical staff, can be uncomfortable for patients, require removal of staples, and may lead to significant scarring.

Solution

Opus KSD provides the SubQ It! bioabsorbable dermal fastener, a skin closure system designed for rapid subcuticular closure of small and laparoscopic incisions, eliminating the need for staple removal and offering improved cosmetic results.

Verdict

Investors backed this seed round because the solution offered a direct, tangible replacement for an existing, problematic medical procedure. This cleared because it proposed clear clinical and operational benefits, not because it introduced a novel therapeutic pathway. They were implicitly betting on market adoption driven by surgeon preference for efficiency and patient demand for better cosmetic outcomes, anticipating a clear value proposition for hospital procurement. The upside was limited by the single-product focus and the assumed ability to navigate a highly regulated market with established incumbents, rather than a broad platform play.

Source: SEC EDGAR Form D filing